1.
Expert Rev Pharmacoecon Outcomes Res
; 2(6): 619-24, 2002 Dec.
Article
in English
| MEDLINE
| ID: mdl-19807486
ABSTRACT
During the last 30 years, therapeutic drug monitoring has evolved from an abstract consideration to a routine intervention. In this increasingly cost-conscious environment, questions are raised about the cost-effectiveness of therapeutic drug monitoring. This review presents the state of therapeutic drug monitoring today, predictions for its near future and the status of economic analyses of the intervention.